For sales representatives
Other
For sales representatives
Regulations for accepting sales representatives in Megrez Sp. z o.o.
1. Each visit of a representative aimed at advertising a medicinal product takes place only with the consent of the Management Board of Megrez Sp. z o. o. or the Deputy Director for Healthcare, provided each time before the scheduled meeting and in accordance with the rules set out in these Regulations. The consent referred to above is granted at the request of the representative, the specimen of which is attached as Appendix 1 to these Regulations.
2. The dates and times of the meetings are determined by the head of the organizational unit of the Company where the meeting is to take place. In order to agree on the date of the meeting, the representative is obliged to present to the Head of the Organizational Unit a document confirming the receipt of the document referred to in point 1 consent.
3. A sales representative is obliged to register his/her presence in the Register of Visits, available at the Company’s secretariat, and to collect an identifier, which he/she is obliged to return after the meeting.
4. Meetings with a sales representative may only be of a group nature, bringing together the personnel of a given organizational unit of the Company.
5. The Pharmacy Manager or a person authorized by him may participate in meetings with a sales representative each time.
6. Information provided by a sales representative as part of advertising a medicinal product must include the following data in accordance with § 12 sec. 1 of the Regulation of the Minister of Health on the advertising of medicinal products (Journal of Laws of 2008, No. 210, item 1327) and art. 54 sec. 1 of the Pharmaceutical Law (Journal of Laws of 2008, No. 45, item 271, as amended):
- the name of the medicinal product and the common name;
- quantitative composition in terms of active substances and those excipients which are essential for proper use;
- indications for use;
- dosage and method of administration; • contraindications;
- special warnings and precautions for use;
- side effects; • indication of the responsible entity;
- marketing authorization number and name of the issuing authority;
- information about the granted accessibility category;
- in the case of reimbursed drugs – information on the official retail price and the maximum amount of co-payment borne by the patient.
- a person authorized to issue prescriptions has requested a representative in writing to provide a sample;
- supplier keeps records of samples delivered;
- the sample is not larger than one smallest package of the medicinal product authorized for marketing in the territory of the Republic of Poland;
- the sample is accompanied by a Summary of Product Characteristics;
- the number of samples of the same medicinal product delivered to the same person does not exceed five packages per year;
- samples must be registered by the Hospital Pharmacy;
- it is forbidden to provide samples of medicinal products containing narcotic drugs or psychotropic substances.
Other